These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9916925)

  • 61. Frequent co-amplification of two different regions on 17q in aneuploid breast carcinomas.
    Latham C; Zhang A; Nalbanti A; Månér S; Zickert P; Blegen H; Zetterberg A
    Cancer Genet Cytogenet; 2001 May; 127(1):16-23. PubMed ID: 11408059
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas.
    Wunder JS; Eppert K; Burrow SR; Gokgoz N; Bell RS; Andrulis IL
    Oncogene; 1999 Jan; 18(3):783-8. PubMed ID: 9989829
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Differential polymerase chain reaction: a technical comparison of three methods for the detection of CDK4 gene amplification in glioblastomas.
    Fan X; Gómez L; Nistal M; Sierrasesúmaga L; Castresana JS
    Int J Oncol; 1998 Nov; 13(5):963-6. PubMed ID: 9772286
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcoma.
    Ragazzini P; Gamberi G; Benassi MS; Orlando C; Sestini R; Ferrari C; Molendini L; Sollazzo MR; Merli M; Magagnoli G; Bertoni F; Bohling T; Pazzagli M; Picci P
    Cancer Detect Prev; 1999; 23(2):129-36. PubMed ID: 10101594
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Analysis of 12q13-15 genes in parosteal osteosarcoma.
    Gamberi G; Ragazzini P; Benassi MS; Ferrari C; Sollazzo MR; Molendini L; Merli M; Magagnoli G; Ruggieri P; Balladelli A; Orlando C; Bacchini P; Pazzagli M; Picci P
    Clin Orthop Relat Res; 2000 Aug; (377):195-204. PubMed ID: 10943202
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Proto-oncogene PIM-1 is a novel estrogen receptor target associating with high grade breast tumors.
    Malinen M; Jääskeläinen T; Pelkonen M; Heikkinen S; Väisänen S; Kosma VM; Nieminen K; Mannermaa A; Palvimo JJ
    Mol Cell Endocrinol; 2013 Jan; 365(2):270-6. PubMed ID: 23142699
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Amplification of the BCAS2 gene at chromosome 1p13.3-21 in human primary breast cancer.
    Maass N; Rösel F; Schem C; Hitomi J; Jonat W; Nagasaki K
    Cancer Lett; 2002 Nov; 185(2):219-23. PubMed ID: 12169396
    [TBL] [Abstract][Full Text] [Related]  

  • 68. DNA polymerase beta gene mutation in human breast cancer.
    Miyamoto H; Miyagi Y; Ishikawa T; Ichikawa Y; Hosaka M; Kubota Y
    Int J Cancer; 1999 Nov; 83(5):708-9. PubMed ID: 10521812
    [No Abstract]   [Full Text] [Related]  

  • 69. Complete scanning of the CDK4 gene by denaturing gradient gel electrophoresis: a novel missense mutation but low overall frequency of mutations in sporadic metastatic malignant melanoma.
    Guldberg P; Kirkin AF; Gronbaek K; thor Straten P; Ahrenkiel V; Zeuthen J
    Int J Cancer; 1997 Sep; 72(5):780-3. PubMed ID: 9311594
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nonsyntenic amplification of MYC with CDK4 and MDM2 in a malignant mixed tumor of salivary gland.
    Rao PH; Murty VV; Louie DC; Chaganti RS
    Cancer Genet Cytogenet; 1998 Sep; 105(2):160-3. PubMed ID: 9723034
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Analysis of MTS1/CDK4 in female breast carcinomas.
    Rush EB; Abouezzi Z; Borgen PI; Anelli A
    Cancer Lett; 1995 Mar; 89(2):223-6. PubMed ID: 7889533
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Association of CDK4 and CCND1 mRNA overexpression in laryngeal squamous cell carcinomas occurs without CDK4 amplification.
    Nadal A; Jares P; Pinyol M; Conde L; Romeu C; Fernández PL; Campo E; Cardesa A
    Virchows Arch; 2007 Feb; 450(2):161-7. PubMed ID: 17139501
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Early overexpression of Cdk4 and possible role of KRF and c-myc in chewing tobacco mediated oral cancer development.
    Mishra R; Das BR
    Mol Biol Rep; 2003 Dec; 30(4):207-13. PubMed ID: 14672406
    [TBL] [Abstract][Full Text] [Related]  

  • 74. PAQR4 has a tumorigenic effect in human breast cancers in association with reduced CDK4 degradation.
    Zhang H; Han R; Ling ZQ; Zhang F; Hou Y; You X; Huang M; Zhao Z; Wang Z; Chen Y
    Carcinogenesis; 2018 Mar; 39(3):439-446. PubMed ID: 29228296
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The utility of immunohistochemistry for providing genetic information on tumors.
    Chan JK; Ip YT; Cheuk W
    Int J Surg Pathol; 2013 Oct; 21(5):455-75. PubMed ID: 24065374
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Assignment of porcine cyclin-dependent kinase 4 (CDK4) and oncogene c-mos (MOS) by nonradioactive nonfluorescence in situ hybridization.
    Musilová P; Kubícková S; Rubes J
    Anim Genet; 2002 Apr; 33(2):145-8. PubMed ID: 12047228
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Slower CDK4 and faster CDK2 activation in the cell cycle.
    Zhang W; Liu Y; Jang H; Nussinov R
    Structure; 2024 Aug; 32(8):1269-1280.e2. PubMed ID: 38703777
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Evolving Pathways of the Efficacy of and Resistance to CDK4/6 Inhibitors in Breast Cancer.
    Gomes I; Abreu C; Costa L; Casimiro S
    Cancers (Basel); 2023 Oct; 15(19):. PubMed ID: 37835528
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The role of miR-369-3p in proliferation and differentiation of preadipocytes in Aohan fine-wool sheep.
    Xue S; Liu K; Zhao L; Zhou L; Gao X; Liu L; Liu N; He J
    Arch Anim Breed; 2023; 66(1):93-102. PubMed ID: 37384329
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario.
    Candido MF; Medeiros M; Veronez LC; Bastos D; Oliveira KL; Pezuk JA; Valera ET; Brassesco MS
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.